Subsequently, BRAF inhibition results in paracrine suppressive activity of melanoma cells on dendritic cells by inhibiting their excretion of pro-inflammatory cytokines, namely IL-12 and tumor necrosis factor alpha (TNFα) [16]. This evidence concerns the gene TNF and melanoma.